Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.

scientific article

Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBRC.2005.07.100
P8608Fatcat IDrelease_vqzsfo5cc5e3pb44542xt53vjm
P698PubMed publication ID16081040

P50authorKoji SodeQ55188802
P2093author name stringNatsuki Kobayashi
Eri Usuzaka
Sayaka Ochiai
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectSynucleinQ24767155
P304page(s)432-436
P577publication date2005-09-01
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleEngineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation
P478volume335

Reverse relations

cites work (P2860)
Q46069820Creation of aggregation-defective α-synuclein variants by engineering the sequence connecting β-strand-forming domains
Q38843614Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability
Q24293089Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity
Q40893529The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein

Search more.